Advertisement

Topics

Sorrento Therapeutics Announced FDA Authorization of IND to Commence Clinical Trial of RTX in ...

12:22 EDT 29 Jun 2017 | BioMedReports - Blog

RTX has been extensively tested in animals and is currently the subject of a Phase I clinical trial at the National Institute of Health (NIH) under

Read more...

Original Article: Sorrento Therapeutics Announced FDA Authorization of IND to Commence Clinical Trial of RTX in ...

NEXT ARTICLE

More From BioPortfolio on "Sorrento Therapeutics Announced FDA Authorization of IND to Commence Clinical Trial of RTX in ..."

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...